A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice

Dendritic cells (DCs), as professional antigen-presenting cells (APCs), play a key role in the initiation and regulation of humoral and cellular immunity. DC vaccines loaded with different tumor-associated antigens (TAAs) have been widely used to study their therapeutic effects on cancer. A number o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jiayi, Zeng, Wuyi, Jia, Jiangtao, Shi, Yi, Wang, Danni, Dong, Jun, Fang, Zixuan, He, Jiashan, Yang, Xinyu, Zhang, Rong, He, Menghua, Huang, Maoping, Fu, Bishi, Zhong, Bei, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325010/
https://www.ncbi.nlm.nih.gov/pubmed/35891256
http://dx.doi.org/10.3390/vaccines10071092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325010/
https://www.ncbi.nlm.nih.gov/pubmed/35891256
http://dx.doi.org/10.3390/vaccines10071092

Ejemplares similares